Enzyme Deficiency clinical trials at UCSF
1 research study open to eligible people
Enzyme deficiency means the body doesn't make an enzyme it needs for normal function. UCSF is running a clinical trial called the SPLIS Observational Study and Patient Registry. This trial aims to learn more about sphingosine phosphate lyase insufficiency syndrome, a type of enzyme deficiency, by observing patients over time.
SPL Insufficiency Syndrome (SPLIS)/NPHS14: a SPLIS Observational Study and Patient Registry (International)
open to all eligible people
This protocol aims to characterize the natural history of sphingosine phosphate lyase insufficiency syndrome (SPLIS), also known as NPHS14, and to create a SPLIS patient registry. Medical records, radiological and pathology results, blood test results, and genetic information will be collected. Samples of blood, cheek cells, urine and stool may be collected for analysis. If a skin biopsy has been performed for medical care, cells from the biopsy may be analyzed. No treatment or other intervention is involved in this study. However, the effect of treatments administered by the patient's physician may be detected and monitored based on changes in the blood or urine.
San Francisco, California
Our lead scientists for Enzyme Deficiency research studies include Julie D Saba, MD, PhD.